Salmonella
- Always repeat blood cultures to ensure clearance of bacteremia.
- Recurrent bacteremia requires further investigation for occult focus of infection and/or underlying immunosuppression.
Previously healthy children:
- Typically related to gastroenteritis
Rule out potential exposure to pets
- Vast majority recover uneventfully with antibiotic therapy.
- In young infants (< 1 year), may progress to meningitis.
Adults:
- Respiratory symptoms and hepatosplenomegaly common with invasive disease.
- Risk factors for invasive disease include malignancy, HIV, diabetes, prior antibiotic therapy and immunosuppressive drugs, including chronic corticosteroids.
- Bacteremia may indicate underlying immunodeficiency, especially for relapsing/recurrent infections. Always consider and test for HIV infection.
- Bacteremia may progress to other body sites, including the urinary tract, lung/pleura, endovascular/heart, bone, muscle, or central nervous system
Salmonella urinary tract infection may represent retrograde infection or chronic infection.
Endovascular infection can occur in up to 20% of adults > 50 years old with bacteremia, hence the rationale for more aggressive therapy of Salmonella gastroenteritis in this age group. Endovascular infection typically presents with fever (subacute/low grade) and back/abdominal pain.
Bacteremia related to gastroenteritis (no extra-intestinal infection)
Therapy | Dose | Duration |
---|---|---|
Dependent on susceptibility results | For pediatric patients, see pediatric dosing. | |
Ceftriaxone | 2g IV daily | See Duration |
or | ||
Ciprofloxacin | 400mg IV q12h/500mg PO bid | See Duration |
or | ||
TMP/SMX | 8-10mg TMP/kg/day IV/PO div q8h | See Duration |
Bacteremia with extraintestinal infection
- High potential for relapse; chronic suppressive therapy with TMP/SMX or quinolone typically required.
- ID consult recommended.
Therapy | Dose | Duration |
---|---|---|
Dependent on susceptibility results | For pediatric patients, see pediatric dosing. | |
Ceftriaxone | 2g IV daily | See Duration |
or | ||
Ciprofloxacin | 400mg IV q12h/750mg PO bid | See Duration |
or | ||
TMP/SMX | 8-10mg TMP/kg/day IV/PO div q8h | See Duration |